Talis Biomedical Corp
Change company Symbol lookup
Select an option...
TLIS Talis Biomedical Corp
PXSAW Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025
TAP Molson Coors Beverage Co
CLS Celestica Inc
TWOU 2U Inc
CGTX Cognition Therapeutics Inc
BHAT Blue Hat Interactive Entertainment Technology
DBTX Decibel Therapeutics Inc
CLSK CleanSpark Inc
AER AerCap Holdings NV
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. It is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). It is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.

Postmarket

Last Trade
Delayed
$0.862
0.041 (4.99%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.821
Day's Change
-0.0191 (-2.27%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
0.848
Day's Low
0.821
Volume
(Light)
Volume:
43,329

10-day average volume:
315,282
43,329
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.